UnitedHealth Group Inc. (NYSE:UNH) is one of the most oversold S&P 500 stocks so far in 2025. While the stock was down only ...

UnitedHealth Group (UNH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” second quarter 2025 investor ...

UnitedHealth Group's recent stock plunge presents a compelling buy for value seekers. After missing earnings expectations and ...

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by next year, the ...

Key Points It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high.Shares of Novo Nordisk and UnitedHealth Group have been beaten down to less than half their ...

UnitedHealth's stock drop offers a rare value opportunity given recent acquisitions. UNH maintains industry-leading margins ...

Not all stocks in the index are doing well. If you're hunting for beaten-down bargains, these two laggards should top your ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

UnitedHealth stock has plunged over 40% in 2025 and is approaching a key buy zone ahead of the Q2 2025 earnings.

As demolition continues on one part of the former AMS/UnitedHealth site, construction on another portion could begin soon.

Now let’s talk about what’s happened to the stock, because it’s been on a wild ride. Back in June 2013, UNH was trading at ...